Skip to main content

TRV GP IV, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1688325 Boston, MA

Position in TNGX

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$133,356,088
+$63,587,363 QoQ
Shares Held
6,374,574
-19.0% QoQ
Ownership
4.41%
of shares outstanding
% of Portfolio
49.96%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TNGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TRV GP IV, LLC holds $266,903,734 across 2 Biotechnology names. TNGX ranks #2 (50.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TNGX
Tango Therapeutics, Inc.
This page
6,374,574 $133,356,088

All Filings in TNGX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $133,356,088 6,374,574
2025-12-31 $69,768,725 7,874,574
2025-09-30 $116,457,390 13,863,975
2025-06-30 $86,318,464 16,859,075
2025-03-31 $23,096,932 16,859,075
2024-12-31 $52,094,541 16,859,075
2024-09-30 $129,814,877 16,859,075
2024-06-30 $164,748,655 19,201,475
2024-03-31 $152,459,711 19,201,475
2023-12-31 $191,703,352 19,363,975
2023-09-30 $218,038,358 19,363,975
2023-06-30 $64,288,397 19,363,975
2023-03-31 $76,487,701 19,363,975
2022-12-31 $140,388,818 19,363,975
2022-09-30 $70,097,589 19,363,975
2022-06-30 $87,718,806 19,363,975
2022-03-31 $146,778,930 19,363,975
2021-12-31 $211,841,886 19,363,975
2021-09-30 $250,376,196 19,363,975